Cucurbitane-triterpenoid compounds, pharmaceutical composition, use and preparation method thereof
    1.
    发明授权
    Cucurbitane-triterpenoid compounds, pharmaceutical composition, use and preparation method thereof 有权
    葫芦巴三萜类化合物,药物组合物及其制备方法

    公开(公告)号:US08669244B2

    公开(公告)日:2014-03-11

    申请号:US13173200

    申请日:2011-06-30

    摘要: Disclosed is a cucurbitane-triterpenoid compound for activating estrogen receptor activity, and a pharmaceutical composition, use and preparation method thereof. The cucurbitane-triterpenoid compound is presented as formula (I): wherein a single bond or a double bond is formed between C5 and C10, and a single bond or a double bond is fromed between C8 and C9; when a single bond is formed between C5 and C10, the R1 is oxygen; while a single bond is formed between C8 and C9, R2 is carbonyl group (—C═O), methyl hydroxyl group (—CH(OH)), methyl ketone or methyl dimethoxy group (—CH(OCH3)2); and wherein while R1 is oxygen (—O—) and R2 is carbonyl group (—C═O) or methyl hydroxyl group (—CH(OH)), a single bond is formed between R1 (—O—) and C19 of R2 such that R1 and R2 are formed tetrahydro-2H-pyran-2-one or hemiacetal ring.

    摘要翻译: 公开了用于激活雌激素受体活性的葫芦巴 - 三萜化合物及其药物组合物的用途及制备方法。 葫芦巴 - 三萜化合物以式(I)表示:其中C5和C10之间形成单键或双键,在C8和C9之间形成单键或双键; 当在C5和C10之间形成单键时,R1是氧; 而在C8和C9之间形成单键,R2是羰基(-C = O),甲基羟基(-CH(OH)),甲基酮或甲基二甲氧基(-CH(OCH 3)2))。 并且其中当R 1是氧(-O-)和R 2是羰基(-C = O)或甲基羟基(-CH(OH))时,在R 2(-O-)和C 19之间形成单键 使得R1和R2形成四氢-2H-吡喃-2-酮或半缩醛环。

    Estrogenic-active compounds and application thereof
    2.
    发明授权
    Estrogenic-active compounds and application thereof 有权
    雌激素活性化合物及其应用

    公开(公告)号:US07902384B2

    公开(公告)日:2011-03-08

    申请号:US12418490

    申请日:2009-04-03

    IPC分类号: C07D315/00

    摘要: The present invention relates to compounds having estrogenic activity selected from the group consisting of Loliolide, (4S,6S)-4-Hydroxy-6-nonadecyl-tetrahydro-pyran-2-one, (4R,6S)-4-Hydroxy-6-nonadecyl-tetrahydro-pyran-2-one and analogues thereof. The compounds of the present invention are selective estrogen receptor modulator, which can selectively activate ERβ and simultaneously express high estrogenic activity, and also can be applied as medical or food compositions to improve estrogen deficiency-related symptoms.

    摘要翻译: 本发明涉及具有选自下组的雌激素活性的化合物:(L,R),(4S,6S)-4-羟基-6-十九烷基 - 四氢吡喃-2-酮,(4R,6S)-4-羟基-6 - 十二烷基 - 四氢 - 吡喃-2-酮及其类似物。 本发明的化合物是选择性雌激素受体调节剂,其可以选择性地激活ER和bgr; 同时表现出较高的雌激素活性,也可用作医药或食品组合物,以改善与雌激素缺乏有关的症状。

    ESTROGENIC-ACTIVE COMPOUNDS AND APPLICATION THEREOF
    3.
    发明申请
    ESTROGENIC-ACTIVE COMPOUNDS AND APPLICATION THEREOF 有权
    雌激素活性化合物及其应用

    公开(公告)号:US20100125102A1

    公开(公告)日:2010-05-20

    申请号:US12418490

    申请日:2009-04-03

    摘要: The present invention relates to compounds having estrogenic activity selected from the group consisting of Loliolide, (4S,6S)-4-Hydroxy-6-nonadecyl-tetrahydro-pyran-2-one, (4R,6S)-4-Hydroxy-6-nonadecyl-tetrahydro-pyran-2-one and analogues thereof. The compounds of the present invention are selective estrogen receptor modulator, which can selectively activate ERβ and simultaneously express high estrogenic activity, and also can be applied as medical or food compositions to improve estrogen deficiency-related symptoms.

    摘要翻译: 本发明涉及具有选自下组的雌激素活性的化合物:(L,R),(4S,6S)-4-羟基-6-十九烷基 - 四氢吡喃-2-酮,(4R,6S)-4-羟基-6 - 十二烷基 - 四氢 - 吡喃-2-酮及其类似物。 本发明的化合物是选择性雌激素受体调节剂,其可以选择性地激活ER和bgr; 同时表现出较高的雌激素活性,也可用作医药或食品组合物,以改善与雌激素缺乏有关的症状。

    METHOD FOR ALLEVIATING ALLERGIC ASTHMA AND ALLERGIC RESPONSE BY USING BITTER MELON COMPOSITION
    4.
    发明申请
    METHOD FOR ALLEVIATING ALLERGIC ASTHMA AND ALLERGIC RESPONSE BY USING BITTER MELON COMPOSITION 审中-公开
    通过使用双体梅隆组合物来表达过敏性哮喘和过敏反应的方法

    公开(公告)号:US20130005812A1

    公开(公告)日:2013-01-03

    申请号:US13484716

    申请日:2012-05-31

    摘要: Disclosed is a method for alleviating allergic asthma by using a bitter melon composition. The bitter melon composition comprises at least an effective amount of conjugated linolenic acid (CLN), wherein the bitter melon composition is administered to a subject suffering from allergic asthma to alleviate its symptoms. In the future, the bitter melon composition can be developed to as a health food, so as to prevent asthma, or alleviate the various symptoms of allergic asthma, such as airway hyperresponsiveness (AHR), airway inflammation, infiltration of inflammatory cell in lung tissue, or high level of serum IgE.

    摘要翻译: 公开了通过使用苦瓜组合物来减轻过敏性哮喘的方法。 苦瓜组合物至少包含有效量的共轭亚麻酸(CLN),其中将苦瓜组合物施用于患有过敏性哮喘的受试者以缓解其症状。 未来,苦瓜的组成可以发展为保健食品,以防止哮喘,或减轻过敏性哮喘的各种症状,如气道高反应性(AHR),呼吸道炎症,肺组织炎症细胞浸润 ,或高水平的血清IgE。

    Cucurbitane-Triterpenoid Compounds, Pharmaceutical Composition, Use and Preparation Method Thereof
    5.
    发明申请
    Cucurbitane-Triterpenoid Compounds, Pharmaceutical Composition, Use and Preparation Method Thereof 有权
    葫芦烷 - 三萜类化合物,药物组合物及其制备方法

    公开(公告)号:US20120252772A1

    公开(公告)日:2012-10-04

    申请号:US13173200

    申请日:2011-06-30

    摘要: Disclosed is a cucurbitane-triterpenoid compound for activating estrogen receptor activity, and a pharmaceutical composition, use and preparation method thereof. The cucurbitane-triterpenoid compound is presented as formula (I): wherein a single bond or a double bond is formed between C5 and C10, and a single bond or a double bond is fromed between C8 and C9; when a single bond is formed between C5 and C10, the R1 is oxygen; while a single bond is formed between C8 and C9, R2 is carbonyl group (—C═O), methyl hydroxyl group (—CH(OH)), methyl ketone or methyl dimethoxy group (—CH(OCH3)2); and wherein while R1 is oxygen (—O—) and R2 is carbonyl group (—C═O) or methyl hydroxyl group (—CH(OH)), a single bond is formed between R1 (—O—) and C19 of R2 such that R1 and R2 are formed tetrahydro-2H-pyran-2-one or hemiacetal ring.

    摘要翻译: 公开了用于激活雌激素受体活性的葫芦巴 - 三萜化合物及其药物组合物的用途及制备方法。 葫芦巴 - 三萜化合物以式(I)表示:其中C5和C10之间形成单键或双键,在C8和C9之间形成单键或双键; 当在C5和C10之间形成单键时,R1是氧; 而C8和C9之间形成单键,R2是羰基(-C = O),甲基羟基(-CH(OH)),甲基酮或甲基二甲氧基(-CH(OCH 3)2))。 并且其中当R1是氧(-O-)和R2是羰基(-C = O)或甲基羟基(-CH(OH))时,在R2的R1(-O-)和C19之间形成单键 使得R1和R2形成四氢-2H-吡喃-2-酮或半缩醛环。

    PROCESS FOR PREPARATION OF AGLUCONE ISOFLAVONES
    6.
    发明申请
    PROCESS FOR PREPARATION OF AGLUCONE ISOFLAVONES 审中-公开
    制备AGLUCONE ISOFLAVONES的方法

    公开(公告)号:US20100190844A1

    公开(公告)日:2010-07-29

    申请号:US12358938

    申请日:2009-01-23

    IPC分类号: A61K31/352 C12P17/06

    CPC分类号: C12P17/06

    摘要: The present invention provides a process for producing a composition containing a high concentration of aglucone isoflavones, which comprises adding glucone isoflavones to the fermentation of microorganisms which are generally recognized as safe, and can express or produce β-glycosidase on a soy-based substrate. The present invention also provides a composition containing a high concentration of aglucone isoflavones produced in accordance with the process of the invention.

    摘要翻译: 本发明提供一种制备含有高浓度配基异黄酮的组合物的方法,该方法包括向通常被认为是安全的微生物的发酵中加入葡萄糖异黄酮,并且可以在大豆基底物上表达或产生'糖苷酶 。 本发明还提供了含有根据本发明方法生产的高浓度配基异黄酮的组合物。